Research and analysis

Genetically Modified Organisms: ILiAD Biotechnologies, LLC (22/R53/01)

Details of the consent for ILiAD Biotechnologies to release a genetically modified organism (GMO), reference 22/R53/01.

Documents

Consent letter

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Part A1: Information required under schedule 2 of the Genetically Modified organisms (Deliberate Release) Regulations 2002

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Part B: Information about the release application to be included on the public register

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Consent documents for ILiAD Biotechnologies, LLC to release genetically modified organisms for research purposes.

Each consent granted includes:

  • consent letter (confirming consent and outlining any conditions)
  • part A (1 - 6): Information required under schedule 1 of the Genetically Modified Organisms (Deliberate Release) regulations 2002
  • part B: Information about the release application to be included on the public register

ACRE advice

Updates to this page

Published 15 February 2022
Last updated 23 June 2022 + show all updates
  1. This application has received ministerial consent. The letter of consent has been attached and the page details have been updated accordingly.

  2. First published.

Sign up for emails or print this page